Research Article Aminated Graphene Oxide as a Potential New Therapy for Colorectal Cancer Natalia Krasteva , 1 Milena Keremidarska-Markova , 1 Kamelia Hristova-Panusheva , 1 Tonya Andreeva , 1 Giorgio Speranza , 2 Dayong Wang, 3 Milena Draganova-Filipova, 4,5 George Miloshev, 6 and Milena Georgieva 6 1 Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences, Acad. Georgi Bonchev, Str., Bl. 21, Soa 1113, Bulgaria 2 University of Trento, Via alla Cascata, 56/C, 38123 Povo, Trento, Italy 3 Medical School in Southeast University, 87 Dingjiaqiao Road, Gulou District, Nanjing 210009, China 4 Department of Medical Biology, Medical Faculty, Medical University Plovdiv, Bulgaria 5 Technological Centre of Emergency Medicine, Vasil Aprilov, Blvd. 15A, Plovdiv 4000, Bulgaria 6 Institute of Molecular Biology Acad. R. Tsanev, Bulgarian Academy of Sciences, Acad. Georgi Bonchev, Str., Bl. 21, Soa 1113, Bulgaria Correspondence should be addressed to Milena Georgieva; milenaki@chromatinepigenetics.com Received 8 November 2018; Revised 17 December 2018; Accepted 3 February 2019; Published 20 March 2019 Academic Editor: Mikko O. Laukkanen Copyright © 2019 Natalia Krasteva et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Nanotechnology-based drug delivery systems for cancer therapy are the topic of interest for many researchers and scientists. Graphene oxide (GO) and its derivates are among the most extensively studied delivery systems of this type. The increased surface area, elevated loading capacity, and aptitude for surface functionalization together with the ability to induce reactive oxygen species make GO a promising tool for the development of novel anticancer therapies. Moreover, GO nanoparticles not only function as eective drug carriers but also have the potential to exert their own inhibitory eects on tumour cells. Recent results show that the functionalization of GO with dierent functional groups, namely, with amine groups, leads to increased reactivity of the nanoparticles. The last steers dierent hypotheses for the mechanisms through which this functionalization of GO could potentially lead to improved anticancer capacity. In this research, we have evaluated the potential of amine-functionalized graphene oxide nanoparticles (GO-NH 2 ) as new molecules for colorectal cancer therapy. For the purpose, we have assessed the impact of aminated graphene oxide (GO) sheets on the viability of colon cancer cells, their potential to generate ROS, and their potential to inuence cellular proliferation and survival. In order to elucidate their mechanism of action on the cellular systems, we have probed their genotoxic and cytostatic properties and compared them to pristine GO. Our results revealed that both GO samples (pristine and aminated) were composed of few-layer sheets with dierent particle sizes, zeta potential, and surface characteristics. Furthermore, we have detected increased cyto- and genotoxicity of the aminated GO nanoparticles following 24-hour exposure on Colon 26 cells. The last leads us to conclude that exposure of cancer cells to GO, namely, aminated GO, can signicantly contribute to cancer cell killing by enhancing the cytotoxicity eect exerted through the induction of ROS, subsequent DNA damage, and apoptosis. 1. Introduction Colorectal cancer (CRC) is the third most diagnosed cancer in men and second most frequently observed cancer in women worldwide [1, 2]. It accounts for over 9% of all cancer death and for over 63% of all cancer cases in the developed countries especially those with a Western culture [3, 4]. In the United States, colorectal cancer is the second leading cause of cancer-related deaths with less than 5-year survival rate for those with the metastatic forms of Hindawi Oxidative Medicine and Cellular Longevity Volume 2019, Article ID 3738980, 15 pages https://doi.org/10.1155/2019/3738980